JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, S.
Right arrow Articles by Guan, K.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, S.
Right arrow Articles by Guan, K.-L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 12, 8854-8862, March 24, 2000

The Dominant Negative Ras Mutant, N17Ras, Can Inhibit Signaling Independently of Blocking Ras Activation*

Scott Stewart and Kun-Liang GuanDagger §

From the Department of Biological Chemistry and the Dagger  Institute of Gerontology, University of Michigan Medical School, Ann Arbor, Michigan 48109

Ras plays an important role in a variety of cellular functions, including growth, differentiation, and oncogenic transformation. For instance, Ras participates in the activation of Raf, which phosphorylates and activates mitogen-activated protein kinase kinase (MEK), which then phosphorylates and activates extracellular signal-regulated kinase (ERK), a mitogen-activated protein (MAP) kinase. Activation of MAP kinase appears to be essential for propagating a wide variety of extracellular signals from the plasma membrane to the nucleus. N17Ras, a GDP-bound dominant negative mutant, is used widely as an interfering mutant to assess Ras function in vivo. Surprisingly, we observed that expression of N17Ras inhibited the activity and phosphorylation of Elk-1, a physiological substrate of MAP kinases, in response to phorbol myristate acetate. The activity and phosphorylation of the MAP kinase hemagglutinin epitope (HA)-ERK1 were not affected by N17Ras in response to the same stimulus. Additionally, expression of N17Ras, but not L61S186Ras, a GTP-bound interfering mutant, inhibited MEK-induced Elk-1 phosphorylation, suggesting that inhibition of Elk-1 may be unique to GDP-bound Ras mutants. Finally, we observed that V12Ras-induced focus formation in NIH3T3 cells is inhibited by coexpression of GDP-bound Ras mutants, such as N17, A15, and N17N69. Therefore, N17Ras and V12 Ras may be codominant with respect to Elk-1 activation and cellular transformation. These results indicate that N17Ras appears to have at least two distinguishable functions: interference with endogenous Ras activation and inhibition of Elk-1 and transfomation. Furthermore, our data imply the possibility that GDP-bound Ras, like N17Ras, may have a direct role in signal transduction.


* This work was supported by the Cancer Biology Training Program, National Institutes of Health, Grant 5T32 CA09676 (to S. S.) and Public Health Service Grant GM51586 (to K.-L. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: M5416 Medical Science I, Dept. of Biological Chemistry, University of Michigan Medical School, 12301 Catherine Rd., Ann Arbor, MI 48109-0606. Tel.: 734-763-3030; Fax: 734-763-4581; E-mail: kunliang@umich.edu.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
P. A. Kelly and Z. Rahmani
DYRK1A Enhances the Mitogen-activated Protein Kinase Cascade in PC12 Cells by Forming a Complex with Ras, B-Raf, and MEK1
Mol. Biol. Cell, August 1, 2005; 16(8): 3562 - 3573.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Singh, A. P. Sowjanya, and G. Ramakrishna
The wild-type Ras: road ahead
FASEB J, February 1, 2005; 19(2): 161 - 169.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Dasgupta, W. Li, A. Perry, and D. H. Gutmann
Glioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes
Cancer Res., January 1, 2005; 65(1): 236 - 245.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
V Stoll, V Calleja, G Vassaux, J Downward, and N R Lemoine
Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer
Gut, January 1, 2005; 54(1): 109 - 116.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Li, K. Inoki, and K.-L. Guan
Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP Activity
Mol. Cell. Biol., September 15, 2004; 24(18): 7965 - 7975.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. K. Chiu, J. Silletti, V. Dinsell, H. Wiener, K. Loukeris, G. Ou, M. R. Philips, and M. H. Pillinger
Carboxyl Methylation of Ras Regulates Membrane Targeting and Effector Engagement
J. Biol. Chem., February 20, 2004; 279(8): 7346 - 7352.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Zheng, J. Li, D. L. Johnson, and J.-h. Ou
Regulation of Hepatitis B Virus Replication by the Ras-Mitogen-Activated Protein Kinase Signaling Pathway
J. Virol., July 15, 2003; 77(14): 7707 - 7712.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Villalonga, C. Lopez-Alcala, A. Chiloeches, J. Gil, R. Marais, O. Bachs, and N. Agell
Calmodulin Prevents Activation of Ras by PKC in 3T3 Fibroblasts
J. Biol. Chem., September 27, 2002; 277(40): 37929 - 37935.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Diaz, D. Ahn, L. Lopez-Barcons, M. Malumbres, I. Perez de Castro, J. Lue, N. Ferrer-Miralles, R. Mangues, J. Tsong, R. Garcia, et al.
The N-ras Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene
Cancer Res., August 1, 2002; 62(15): 4514 - 4518.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. Wu, I. Jaspers, W. Zhang, L. M. Graves, and J. M. Samet
Role of Ras in metal-induced EGF receptor signaling and NF-kappa B activation in human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L1040 - L1048.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
O. Zugasti, W. Rul, P. Roux, C. Peyssonnaux, A. Eychene, T. F. Franke, P. Fort, and U. Hibner
Raf-MEK-Erk Cascade in Anoikis Is Controlled by Rac1 and Cdc42 via Akt
Mol. Cell. Biol., October 1, 2001; 21(19): 6706 - 6717.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. G. Vikis, W. Li, Z. He, and K.-L. Guan
The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner
PNAS, October 12, 2000; (2000) 220421797.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. G. Vikis, W. Li, Z. He, and K.-L. Guan
The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner
PNAS, November 7, 2000; 97(23): 12457 - 12462.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.